Antithrombin Gamma (genetical Recombination) Uses, Dosage, Side Effects and more
Antithrombin Gamma (genetical Recombination) is under investigation in clinical trial NCT04182373 (KW-3357 Study in Patients With Early Onset Severe Preeclampsia).
| Attribute | Details |
|---|---|
| Trade Name | Antithrombin Gamma (genetical Recombination) |
| Generic | Antithrombin gamma |
| Antithrombin gamma Other Names | Acoalan, Afucosylated antithrombin, Antithrombin (human variant kw-3357), Antithrombin gamma, Antithrombin gamma (genetical recombination), Human antithrombin-iii (atiii, serpin c1) expressed in fucosyl transferase-negative chinese hamster ovary (cho) cells (glycoform gamma) |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
